Giorgia Gobbi da Silveira, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromones | 1 | 2019 | 165 | 0.370 |
Why?
|
Neoplastic Stem Cells | 3 | 2021 | 1371 | 0.350 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2019 | 132 | 0.350 |
Why?
|
Carcinoma, Ductal, Breast | 3 | 2012 | 1103 | 0.310 |
Why?
|
Mouth Neoplasms | 3 | 2019 | 614 | 0.300 |
Why?
|
Morpholines | 1 | 2019 | 571 | 0.300 |
Why?
|
Immunophenotyping | 3 | 2013 | 1894 | 0.240 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2012 | 98 | 0.220 |
Why?
|
Lymphangiogenesis | 1 | 2013 | 185 | 0.220 |
Why?
|
Cell Nucleus | 1 | 2020 | 2993 | 0.210 |
Why?
|
DNA Repair Enzymes | 1 | 2021 | 356 | 0.190 |
Why?
|
Lymphatic Vessels | 1 | 2013 | 328 | 0.190 |
Why?
|
Salivary Gland Neoplasms | 1 | 2013 | 294 | 0.180 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2011 | 619 | 0.180 |
Why?
|
Cell Survival | 1 | 2019 | 6032 | 0.180 |
Why?
|
Enzyme Inhibitors | 1 | 2019 | 3895 | 0.170 |
Why?
|
Open Reading Frames | 1 | 2021 | 833 | 0.170 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3427 | 0.160 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2019 | 3991 | 0.150 |
Why?
|
Glycolysis | 1 | 2021 | 810 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2013 | 3491 | 0.120 |
Why?
|
Tissue Array Analysis | 3 | 2013 | 573 | 0.120 |
Why?
|
Cell Proliferation | 1 | 2019 | 10603 | 0.120 |
Why?
|
DNA Repair | 1 | 2021 | 2033 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 5 | 2015 | 6726 | 0.110 |
Why?
|
DNA Damage | 1 | 2021 | 2432 | 0.110 |
Why?
|
Histones | 1 | 2021 | 2550 | 0.100 |
Why?
|
Carcinoma | 1 | 2013 | 2320 | 0.100 |
Why?
|
Chromatin | 1 | 2021 | 2683 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 1 | 2012 | 4642 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2015 | 871 | 0.090 |
Why?
|
Lymphatic Metastasis | 3 | 2015 | 2967 | 0.080 |
Why?
|
Breast Neoplasms | 3 | 2012 | 20060 | 0.080 |
Why?
|
Proportional Hazards Models | 5 | 2015 | 12495 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2021 | 2718 | 0.080 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 630 | 0.080 |
Why?
|
Mucin-1 | 1 | 2011 | 529 | 0.080 |
Why?
|
Pancreatic Neoplasms | 1 | 2013 | 4978 | 0.070 |
Why?
|
Immunohistochemistry | 4 | 2013 | 11665 | 0.070 |
Why?
|
Signal Transduction | 1 | 2019 | 23721 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2013 | 6320 | 0.070 |
Why?
|
Metabolic Networks and Pathways | 1 | 2020 | 814 | 0.070 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3543 | 0.070 |
Why?
|
Cell Hypoxia | 2 | 2011 | 682 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1369 | 0.060 |
Why?
|
Moloney murine leukemia virus | 1 | 2012 | 140 | 0.060 |
Why?
|
Genome | 1 | 2020 | 1752 | 0.060 |
Why?
|
Prognosis | 5 | 2015 | 28987 | 0.050 |
Why?
|
Pancreatitis, Chronic | 1 | 2013 | 259 | 0.050 |
Why?
|
Pentose Phosphate Pathway | 1 | 2021 | 125 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2015 | 58288 | 0.050 |
Why?
|
Virus Integration | 1 | 2012 | 300 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2552 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 8561 | 0.040 |
Why?
|
Glutathione | 1 | 2021 | 606 | 0.040 |
Why?
|
Survival Rate | 2 | 2013 | 13210 | 0.040 |
Why?
|
RNA, Neoplasm | 1 | 2021 | 774 | 0.040 |
Why?
|
Phosphorylation | 1 | 2019 | 8654 | 0.040 |
Why?
|
Sirtuins | 1 | 2021 | 367 | 0.040 |
Why?
|
Brazil | 1 | 2011 | 1154 | 0.040 |
Why?
|
Blood Vessels | 1 | 2013 | 1153 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2013 | 7014 | 0.040 |
Why?
|
High-Throughput Screening Assays | 1 | 2021 | 931 | 0.040 |
Why?
|
Disease Progression | 2 | 2021 | 13219 | 0.030 |
Why?
|
Tissue Banks | 1 | 2015 | 194 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3681 | 0.030 |
Why?
|
Middle Aged | 7 | 2015 | 214618 | 0.030 |
Why?
|
Kinetics | 1 | 2021 | 6654 | 0.030 |
Why?
|
Aged | 6 | 2015 | 162383 | 0.030 |
Why?
|
Regression Analysis | 1 | 2013 | 6499 | 0.030 |
Why?
|
Humans | 11 | 2021 | 715636 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2013 | 11138 | 0.030 |
Why?
|
Apoptosis | 1 | 2019 | 9962 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16729 | 0.030 |
Why?
|
Antioxidants | 1 | 2021 | 1672 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2013 | 2696 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3631 | 0.030 |
Why?
|
Adult | 6 | 2015 | 212228 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2011 | 2309 | 0.030 |
Why?
|
Cytoplasm | 1 | 2015 | 1625 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2011 | 662 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2129 | 0.020 |
Why?
|
Risk Assessment | 2 | 2012 | 23482 | 0.020 |
Why?
|
Female | 7 | 2015 | 377052 | 0.020 |
Why?
|
Animals | 3 | 2021 | 169277 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2012 | 4905 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12490 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15184 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2011 | 1119 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 4036 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 2446 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 15051 | 0.020 |
Why?
|
Risk Factors | 2 | 2013 | 70927 | 0.020 |
Why?
|
Mice | 2 | 2021 | 80320 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 8892 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2973 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2104 | 0.020 |
Why?
|
Male | 4 | 2015 | 350156 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2172 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2015 | 62037 | 0.010 |
Why?
|
NF-kappa B | 1 | 2011 | 2553 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22648 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2011 | 2943 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 40892 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2013 | 72439 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 11099 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9498 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9741 | 0.010 |
Why?
|
Young Adult | 1 | 2013 | 56137 | 0.010 |
Why?
|
Adolescent | 1 | 2013 | 85064 | 0.010 |
Why?
|
Cohort Studies | 1 | 2015 | 40042 | 0.010 |
Why?
|